Elsevier

Vaccine

Volume 23, Issue 14, 25 February 2005, Pages 1746-1751
Vaccine

Childhood mortality after oral polio immunisation campaign in Guinea-Bissau

https://doi.org/10.1016/j.vaccine.2004.02.054Get rights and content

Abstract

Though previous studies have suggested a non-specific beneficial effect of oral polio vaccine (OPV), there has been no evaluation of the mortality impact of national polio immunization days. On the other hand, studies examining the effect of OPV and diphtheria–tetanus–pertussis (DTP) vaccines, which are usually administered together in routine immunisation programmes in low-income countries, have found no beneficial or even a negative effect on infant survival. In 1998, we used the opportunity of two national immunisation days to examine the impact of OPV administered alone on survival for the 6103 children less than 5 years of age in the Bandim Health Project's study area in Guinea-Bissau. Survival was ascertained through regular surveillance from March 1998 until the beginning of the war on June 7, 1998, the end of 1998, or the end of 1999, respectively. The child register was linked with a register for the only paediatric ward in Bissau to determine the risk of hospitalisations. Among children under 5 years of age, 82% had received 1 or 2 doses of polio vaccines during the campaign. Though polio vaccination during the campaign was associated with slightly lower mortality, this difference was not significant for all children under 5 years of age (mortality ratio (MR) = 0.46 (0.18–1.15)). However, oral polio vaccination was associated with a beneficial effect for children under 6 months of age at the time of the campaign, the mortality ratio being 0.09 (95% CI 0.01–0.85) in the 3 months before the war controlling for significant background factors, including routine immunizations, antenatal consultations, and arm circumference. The polio-vaccinated children aged 0–5 months had fewer hospitalisations than children who had not been polio vaccinated (RR = 0.27 (0.10–0.76)). With longer follow-up to December 1998 or December 1999, the difference in mortality gradually disappeared, the MR for polio-vaccinated children being 0.61 (0.32–1.14) and 0.83 (0.51–1.34), respectively. Among children aged 6–59 months of age, measles vaccine was associated with a 56% reduction in mortality (MR = 0.44 (0.28–0.69)) and no effect of oral polio vaccine was measurable in this age group. The effect of polio vaccine among children less than 6 months of age could be due to selection bias but might also represent a non-specific beneficial immune stimulation and there is nothing to suggest that OPV might have a negative effect on infant survival. Studies of the possible non-specific effects of oral polio vaccine are warranted before OPV is withdrawn.

Introduction

When oral polio was introduced in the 1960s, a Chilean study observed a significant reduction in mortality and suggested that Sabin's oral polio vaccine virus limited other enteroviruses [1]. In studies conducted in the Soviet Union in the 1950s and 1960s, Voroshilova found marked reduction in morbidity associated with the use of non-pathogenic enterovirus vaccines including oral polio vaccine (OPV) [2]. If such effects were indeed true, it would add to the value of national polio immunisation days but would also question the health impact of dropping oral polio vaccination in the later stages of polio eradication [3]. Surprisingly, the effect of national polio immunization days on morbidity and mortality has not been examined previously.

The major reason for undertaking the present study was the observation that routine immunisations may have important non-specific effects for childhood survival [4], [5], [6], [7], [8]. BCG and measles vaccine have been associated with marked reduction in mortality, which cannot be explained by the prevention of measles or tuberculosis [4], [5]. However, diphtheria, tetanus, pertussis (DTP) and OPV have been associated with no reduction or slightly increased mortality [4], [5], [7], [8]. Since DTP and polio vaccines are usually administered together at 6, 10, and 14 weeks of age in the immunisation programme in low-income countries, it is difficult to distinguish the effects of these vaccines. We therefore used the opportunity of national polio immunisation days in 1998 in Guinea-Bissau to assess the effect on child survival of oral polio vaccine administered alone.

Section snippets

Subjects and methods

The Bandim Health Project (BHP) has maintained a population register for the inhabitants of the districts of Bandim 1, Bandim 2, Belem, and Mindara in the capital of Guinea-Bissau since 1978, 1984, 1984, and 1995, respectively. All houses in the study area are visited monthly to identify pregnant women and newborn children. Field workers from the Bandim Health Project (BHP) visit all children at home every 3 months until the age of 3 years. Information is collected routinely on breastfeeding

Results

A total of 6159 children less than 5 years of age were registered in the area. When houses were visited in March 1998, 6103 were still living in the area. Information on polio vaccination could not be obtained for 19.0% (1162/6103) of the children, mainly because the family was travelling. Of the children less than 5 years of age, 17.7% (875/4941) had not received polio vaccine. Many had been travelling while the campaign was conducted. The vaccination coverage differed by source of

Discussion

Our data suggest that OPV administered alone during the campaign was not associated with any adverse morbidity or mortality and might even be associated with a lower risk of hospitalisation and mortality for the youngest children less than 6 months of age. As in several other studies [4], there was a marked beneficial effect of measles vaccine, mortality being 56% lower among measles-vaccinated children (Table 2). Given the strong effect of measles vaccine, the effects of other vaccines are

Acknowledgements

Contributors: The study was planned in 1998 by PA, AS, EN, IL, and HJ. JEV maintained the hospital register. HJ, MS and MJ were responsible for survival follow-up after the war. KH and HJ carried out the statistical analyses. PA wrote the first version of the paper and all authors contributed to the final version. Coflict of interest statement: None declared. Funding: Research was funded from ECHO, Bruxelles, the Council for Development Research, Denmark, and the EU Commission (IC18CT95-0011).

References (19)

There are more references available in the full text version of this article.

Cited by (43)

  • Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies

    2019, Clinical Microbiology and Infection
    Citation Excerpt :

    In the pre-vaccination era in West Africa, girls did not have higher mortality than boys [65]. In the pursuit of the non-specific effects of vaccines, in the 1990s, the Bandim Health Project in Guinea-Bissau therefore initiated new studies, not only of smallpox vaccine, BCG and OPV, but also of DTP, hepatitis B vaccine (HBV) and IPV [2,65–68]. As of today, beneficial NSEs have been shown for four live vaccines [41,42,58,61,69].

  • Non-specific effects of childhood vaccinations – A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso

    2017, Vaccine
    Citation Excerpt :

    Evidence from observational studies indicates that inactivated vaccines such as diphtheria-tetanus-pertussis (DTP), hepatitis B (HBV) and polio (IPV) vaccines are associated with increased overall mortality in young girls, in spite of protection against the targeted diseases [19,21,22,25,26]. In contrast, the live measles vaccine (MV), Bacille Calmette-Guerin (BCG) and oral polio vaccine (OPV) have been shown to reduce mortality [27,28]. These contrasting effects have often been observed in the same populations [29], suggesting that inactivated and live vaccines leave the immune system in very different states.

  • Campaigns with oral polio vaccine may lower mortality and create unexpected results

    2017, Vaccine
    Citation Excerpt :

    Thus, from the specific disease perspective, repeated doses are not expected to have an impact on overall health. Overall, there is now considerable evidence that OPV, like other live vaccines, has important beneficial non-specific effects [6–10]. In conclusion, OPV campaigns may have important mortality reducing effects, and different intensities of OPV campaigns between different vaccine studies may give rise to spurious differences in study results.

View all citing articles on Scopus
View full text